-
Sun Pharma to acquire Pola Pharma in Japan
Pola Pharma is a leading dermatology company and it will help us to launch our speciality and generic dermatology products in the Japane...
2018-12-10 10:29 -
New norms likely for drug distribution and storage
There have been several instances when popular medicines, including pain-killers, vitamins, antibiotics, anti-allergics have disintegrat...
2018-12-10 10:08 -
Indoco's Goa Plant II & III clears USFDA inspection
Indoco is committed to its philosophy of highest quality in manufacturing, operations, systems integrity and cGMP culture,” said Ms.
2018-12-10 10:02 -
CII-PwC report: 77% Indian households use ayurvedic products
The state is singularly advantaged in its ability to deliver ayurvedic products and services, in all segments of ayurveda, the report said.
2018-12-10 09:48 -
AbbVie's Venclyxto combo beats standard of care in chronic lymphocytic leukaemia
“The results of this analysis showed that a high proportion of patients with relapsed or refractory chronic lymphocytic leukaemia who we...
2018-12-04 15:26 -
Novartis unveils strong longer-term Kymriah data at ASH 2018
"Before CAR-T cell therapy, achieving and maintaining a prolonged complete response in adult patients with relapsed or refractory DLBCL ...
2018-12-04 15:19 -
Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children
The prevalence of ever-diagnosed autism spectrum disorder (ASD) is 2.79 percent in the United States, with state-level variations in prevalence, accor...
2018-12-04 15:19 -
Rare Variants Associated With Interval Breast Cancers
Higher PRS was associated with less aggressive tumor characteristics (estrogen receptor-positive, progesterone receptor-positive, small ...
2018-12-04 14:35 -
Doctors More Cautious Now When Prescribing Opioids to Kids
"Despite the downward trends for opioid prescriptions, the frequency of opioid use remains high given the risks associated with these me...
2018-12-04 14:35 -
Astellas scores first US blood cancer approval with Xospata
“For the first time, people with relapsed or refractory FLT3 mutation-positive AML have an FDA approved FLT3 -targeting treatment availa...
2018-12-03 17:52
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- The Truth Behind the US-China ... Jun 30, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products
Related Producers
